EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Clinical Significance of CD73 in Cancer

Niklas Bach, Riekje Winzer, Eva Tolosa, Walter Fiedler iD, Franziska Brauneck

International Journal of Molecular Sciences · 21.07.2023 · 24 (14) · 11759

DOI: 10.3390/ijms241411759 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 21.07.2023. Verfasst von Niklas Bach und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany. Hauptthemen laut MEDLINE: Clinical Relevance, Neoplasms. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 167 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mildred Scheel Cancer Career Center HaTriCS4 program, DFG, Mildred Scheel Cancer Career Center HaTriCS4, University Medical Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The search for new and effective treatment targets for cancer immunotherapy is an ongoing challenge. Alongside the more established inhibitory immune checkpoints, a novel potential target is CD73. As one of the key enzymes in the purinergic signalling pathway CD73 is responsible for the generation of immune suppressive adenosine. The expression of CD73 is higher in tumours than in the corresponding healthy tissues and associated with a poor prognosis. CD73, mainly by the production of adenosine, is critical in the suppression of an adequate anti-tumour immune response, but also in promoting cancer cell proliferation, tumour growth, angiogenesis, and metastasis. The upregulation of CD73 and generation of adenosine by tumour or tumour-associated immune cells is a common resistance mechanism to many cancer treatments such as chemotherapy, radiotherapy, targeted therapy, and immunotherapy. Therefore, the inhibition of CD73 represents a new and promising approach to increase therapy efficacy. Several CD73 inhibitors have already been developed and successfully demonstrated anti-cancer activity in preclinical studies. Currently, clinical studies evaluate CD73 inhibitors in different therapy combinations and tumour entities. The initial results suggest that inhibiting CD73 could be an effective option to augment anti-cancer immunotherapeutic strategies. This review provides an overview of the rationale behind the CD73 inhibition in different treatment combinations and the role of CD73 as a prognostic marker.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clinical RelevanceNeoplasmsHumans5'-NucleotidaseAdenosineImmunosuppression TherapyImmunotherapyGPI-Linked Proteins

Stichwörter der Autor:innen

CD73cancerimmune suppressionimmunotherapeutic strategies

Substanzen

5'-NucleotidaseAdenosineNT5E protein, humanGPI-Linked Proteins

Autor:innen und Institutionen

  • Department of Immunology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
  • Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald University Cancer Center, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
  • Mildred Scheel Cancer Career Center HaTriCS4, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.

ORCID-Profile: Walter Fiedler

Förderung

  • Mildred Scheel Cancer Career Center HaTriCS4 program
  • DFG
  • Mildred Scheel Cancer Career Center HaTriCS4, University Medical Center
  • German Research Council

Zitieren

APA

Bach, N., Winzer, R., Tolosa, E., Fiedler, W., & Brauneck, F. (2023). The Clinical Significance of CD73 in Cancer. International Journal of Molecular Sciences, 24(14), 11759. https://doi.org/10.3390/ijms241411759

Vancouver

Bach N, Winzer R, Tolosa E, Fiedler W, Brauneck F. The Clinical Significance of CD73 in Cancer. International Journal of Molecular Sciences. 2023;24(14):11759. doi:10.3390/ijms241411759

BibTeX
@article{Bach2023,
  author = {Bach, Niklas and Winzer, Riekje and Tolosa, Eva and Fiedler, Walter and Brauneck, Franziska},
  title = {The Clinical Significance of CD73 in Cancer},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {14},
  pages = {11759},
  doi = {10.3390/ijms241411759}
}
Kostenlos starten →